N-[(1R)-cyclopent-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Structure Info
- Chemspace ID
- CSSB02500519988 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1R)-cyclopent-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
- Mol formula
- C18H24BNO3
- Mol weight
- 313 Da
- Catalog Number(s)
- BBLS02500519988, BBV-306240803, EN300-55398933, bbls02500519988
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.87
- Heavy atoms count
- 23
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 48
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1R)-cyclopent-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (C18H24BNO3) - CSSB02500519988](/st/structure/200/4b1d3fdca777016e72088072a9113d89/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N%255BC%2540%2540H%255D1CCC%253DC1.png "C18H24BNO3")
- Zoom the structure
- CSSB02500519988
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(1S)-cyclopent-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02500519984](/st/structure/200/549d427b3441cfe2aa637966e5dabb67/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N%255BC%2540H%255D1CCC%253DC1.png)
![Chemical structure of 3-(cyclopent-2-en-1-yl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea - CSSB02526935692](/st/structure/200/a51c2c110c52a5c35fafe0aecbf1747f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528NC%2528%253DO%2529NC2CCC%253DC2%2529%253DC1.png)
![Chemical structure of N-[(1S)-cyclopent-2-en-1-yl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522232806](/st/structure/200/39ae6029c453712ab93d401fe0070fbf/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N%255BC%2540H%255D1CCC%253DC1.png)
![Chemical structure of N-[(1R)-cyclopent-2-en-1-yl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522232614](/st/structure/200/d93cd5b60bbe464a5c285468a771e3cd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N%255BC%2540%2540H%255D1CCC%253DC1.png)
